Niox Group

Niox Group EBIT

The EBIT of Niox Group (NIOX.L) as of Nov 5, 2026 is 10.70 M GBP. In the previous year, EBIT was 7.70 M GBP — a change of 38.96% (higher).

EBIT

10.70 MGBP

YoY

38.96%

Last updated:

In 2025, Niox Group's EBIT was 10.70 M GBP, a 38.96% increase from the 7.70 M GBP EBIT recorded in the previous year.

The Niox Group EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
1.80 M GBP
Jan 1, 2023
4.60 M GBP
Jan 1, 2024
7.70 M GBP
Jan 1, 2025
10.70 M GBP
Jan 1, 2026 (e)
19.18 M GBP
Jan 1, 2027 (e)
18.88 M GBP
Jan 1, 2028 (e)
21.74 M GBP
Jan 1, 2029 (e)
35.38 M GBP
The Niox Group EBIT history
YEAREBITYoY
est35.38 MGBP+62.76%
est21.74 MGBP+15.13%
est18.88 MGBP-1.59%
est19.18 MGBP+79.28%
10.70 MGBP+38.96%
7.70 MGBP+67.39%
4.60 MGBP+155.56%
1.80 MGBP-141.86%
-4.30 MGBP-75.14%
-17.30 MGBP-72.88%
-63.80 MGBP+57.92%
-40.40 MGBP-50.85%
-82.20 MGBP+87.67%
-43.80 MGBP-34.04%
-66.40 MGBP+44.98%
-45.80 MGBP+84.71%
-24.80 MGBP+29.55%
-19.14 MGBP+24.67%
-15.35 MGBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Niox Group Revenue

Niox Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
31.30 M GBP
1.80 M GBP
16.10 M GBP
Jan 1, 2023
36.80 M GBP
4.60 M GBP
10.70 M GBP
Jan 1, 2024
41.80 M GBP
7.70 M GBP
3.70 M GBP
Jan 1, 2025
48.70 M GBP
10.70 M GBP
7.00 M GBP
Jan 1, 2026 (e)
50.35 M GBP
19.18 M GBP
11.87 M GBP
Jan 1, 2027 (e)
54.04 M GBP
18.88 M GBP
13.85 M GBP
Jan 1, 2028 (e)
57.79 M GBP
21.74 M GBP
15.71 M GBP
Jan 1, 2029 (e)
65.54 M GBP
35.38 M GBP
21.38 M GBP

Niox Group Margins

Niox Group stock margins

The Niox Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Niox Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Niox Group.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
70.93 %
5.75 %
51.44 %
Jan 1, 2023
72.01 %
12.50 %
29.08 %
Jan 1, 2024
72.25 %
18.42 %
8.85 %
Jan 1, 2025
60.78 %
21.97 %
14.37 %
Jan 1, 2026 (e)
60.78 %
38.10 %
23.58 %
Jan 1, 2027 (e)
60.78 %
34.93 %
25.63 %
Jan 1, 2028 (e)
60.78 %
37.61 %
27.19 %
Jan 1, 2029 (e)
60.78 %
53.97 %
32.62 %

Niox Group Stock analysis

What does Niox Group do? Circassia Group plc is a British biotechnology company specializing in the development of therapies for respiratory diseases. The company was founded in 2006 and is headquartered in Oxford. Circassia was founded by Steve Harris, who previously worked for the biopharmaceutical company Xenova Group plc. In its early years, the company focused on research and development of therapies for allergies and asthma. In 2014, Circassia went public on the London Stock Exchange. The company has developed an innovative business model that focuses on using its proprietary technology platform to identify novel therapy candidates. It works closely with pharmaceutical companies and other partners to accelerate the development of its therapy products and license its technology platform. Circassia's main focus is on developing therapies for respiratory diseases, particularly allergic asthma and chronic obstructive pulmonary disease (COPD). It has a range of products currently in various stages of clinical development. One of its leading products is NIOX VERO, a diagnostic device used to measure inflammation in the airways and improve the diagnosis of patients with asthma or COPD. Circassia also has a promising pipeline of therapy candidates, including Flutiform® (fluticasone propionate/formoterol fumarate), an inhaled medication for the treatment of asthma developed in collaboration with Japanese pharmaceutical company Kyorin. Additionally, the company has developed two novel drugs in the field of allergic rhinoconjunctivitis, one of which is currently being tested in phase III studies, while the other is nearing completion of phase II development. In conclusion, Circassia has established itself as an innovative biotechnology company focused on the development of therapies for respiratory diseases. It has a promising pipeline of therapy candidates at various stages of clinical development. The Circassia business model is based on utilizing its proprietary technology platform to identify and develop novel therapy candidates. Niox Group is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Niox Group's EBIT

Niox Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Niox Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Niox Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Niox Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Niox Group stock

EBIT of Niox Group is 10.70 M GBP in 2025.

EBIT of Niox Group changed from 7.70 M GBP to 10.70 M GBP, representing a 38.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Niox Group since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Niox Group historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Niox Group

All Key Metrics — Niox Group